Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a $1,000 device save money by protecting kidneys during heart surgery?

NCT ID NCT07108634

Summary

This study aimed to see if a medical device called RenalGuard Therapy, which helps manage a patient's fluids during surgery, is worth the cost for the UK's healthcare system. It planned to look back at the medical records of patients who had heart surgery to compare costs and health outcomes between those who did and did not develop kidney injury. The study was withdrawn before any patients were enrolled.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • New Cross Hospital

    Wolverhampton, West Midlands, WV10 0QP, United Kingdom

Conditions

Explore the condition pages connected to this study.